Article info

Download PDFPDF

OP-4 Characterising mirvetuximab-induced ocular surface disease

Authors

Citation

Neo YN, Ahmad S
OP-4 Characterising mirvetuximab-induced ocular surface disease

Publication history

  • First published April 12, 2024.
Online issue publication 
April 12, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.